← FDA Drug Approvals (Drugs@FDA)
JAYPIRCA
NDA · New Drug Application · Sponsor: LOXO ONCOL · Approved 2023-01-27
Drug application
- FDA Application #
NDA216059- Application type
- New Drug Application
- Brand name
- JAYPIRCA
- Generic name
- PIRTOBRUTINIB
- Active ingredients
- PIRTOBRUTINIB
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- LOXO ONCOL
- Manufacturer
- Eli Lilly and Company
- First approval
- 2023-01-27
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown